Gene · 1452
Papers2,578
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,578
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Multifaceted Legacy of Thalidomide: Chemistry and Biology Driving Modern Drug Design. | ChemMedChem | 2026 | 41931005 | PubTator, text mining | PubMed |
| Structural dynamics between Argonaute-2 and CK1α promote target RNA release in microRNA-mediated silencing. | bioRxiv | 2026 | 41929091 | PubTator, text mining | PubMed |
| Colorectal cancer pathogenesis, oncogenic signaling networks and targeted therapeutic advances. | Mol Biomed | 2026 | 41826571 | PubTator, text mining | PubMed |
| Advances in molecular glue degraders for targeted protein degradation: Focus on NEK7, WEE1, CDK2, GSPT1 and VAV1. | Asian J Pharm Sci | 2026 | 41810469 | PubTator, text mining | PubMed |
| DNASE1L3 Mediates Hepatocellular Carcinoma Tumor Growth and Organoid Models via the Wnt/β-Catenin Signaling Pathway. | Oncol Res | 2026 | 41799507 | PubTator, text mining | PubMed |
| Decoding organ fibrosis: mechanistic insights and emerging therapeutic strategies. | Signal Transduct Target Ther | 2026 | 41786685 | PubTator, text mining | PubMed |
| Therapeutic targeting of MALT1 in oncology: Mechanism, inhibitor development, and clinical prospects. | J Cell Commun Signal | 2026 | 41783325 | PubTator, text mining | PubMed |
| Regulation of Autophagy and Metabolism in Hepatocellular Carcinoma: Involvement of Wnt-β-Catenin Pathway. | J Cell Mol Med | 2026 | 41772397 | PubTator, text mining | PubMed |
| Beyond Organ-Specific Therapies: A Unified Approach to Multi-Organ Fibrosis. | Drug Des Devel Ther | 2026 | 41769263 | PubTator, text mining | PubMed |
| Research Advances in Therapeutic Strategies and Drug Delivery Systems for Pathological Scars. | Pharmaceutics | 2026 | 41754891 | PubTator, text mining | PubMed |
| Cancer Stemness and Dedifferentiation in Anaplastic Thyroid Carcinoma: Insights into a Multigenic, Microenvironmental Network and the Role of CD44. | Biomedicines | 2026 | 41751352 | PubTator, text mining | PubMed |
| From fibrotic mechanisms to clinical translation: the drug therapy revolution and delivery system breakthrough in proliferative vitreoretinopathy. | Front Immunol | 2026 | 41743704 | PubTator, text mining | PubMed |
| Human papillomavirus16 E7 enhances cell stemness by regulating the APC2/SPIN4/β-catenin axis in cervical cancer. | Oncogenesis | 2026 | 41730837 | PubTator, text mining | PubMed |
| Wnt-dependent spatiotemporal reprogramming of bone marrow niches drives fibrosis. | Hemasphere | 2026 | 41726391 | PubTator, text mining | PubMed |
| Lifestyle factors affecting the pathogenesis of androgenetic alopecia: a literature review. | Front Public Health | 2026 | 41717597 | PubTator, text mining | PubMed |
| Design, Synthesis, and Structure-Activity Relationship Studies of 7H‑Pyrrolo[2,3‑d]pyrimidine Derivatives as Potent Casein Kinase 1α (CK1α) Inhibitors. | ACS Med Chem Lett | 2026 | 41704356 | PubTator, text mining | PubMed |
| Synovial inflammatory macrophage-derived extracellular vesicles exacerbate cartilage lesions with a FMRP-selectively sorted manner in osteoarthritis. | Bone Res | 2026 | 41702879 | PubTator, text mining | PubMed |
| Discovery of BMS-986458, a Potent and Selective B-Cell Lymphoma 6 Protein Ligand-Directed Degrader, for the Treatment of B-Cell Non-Hodgkin Lymphoma. | J Med Chem | 2026 | 41670385 | PubTator, text mining | PubMed |
| A daily cycle of White Collar Complex dephosphorylation sustains circadian rhythmicity in Neurospora. | Proc Natl Acad Sci U S A | 2026 | 41650222 | PubTator, text mining | PubMed |
| Covalent modification of a glutamic acid inspired by HaloTag technology. | Nat Commun | 2026 | 41617704 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1452/papers?page=2